10 November 2023FeaturesPatentsSarah Gibbs and Emma Lyons

Weight loss drugs: The impact of NICE and the FDA

In March 2023, the National Institute for Health and Care Excellence (NICE) published guidelines recommending the use of semaglutide for weight management. Semigltuide was officially launched for use in the whole of the UK in September 2023.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Huawei wins seven-country ban on Netgear routers at the UPC

Propel Fuels seeks top-up damages of $1.2bn in secrets case

Leading US trademark firms and lawyers recognised in new national rankings

Lenovo faces US import ban as ITC sides with Ericsson

Samsara v Motive: ‘Secrets case reads like a pulp novel’

USPTO sanctions attorney over sham Chinese TM filings

Arusha Protocol takes root: Fresh growth for plant variety protection in Africa

Peanut the squirrel (RIP) leaps on the meme coin bandwagon

Weight loss drugs: The impact of NICE and the FDA

More on this story

Editor's picks

Editor's picks

More articles